Article Details
Retrieved on: 2021-05-06 06:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Invizius Limited, a Motherwell, Scotland, UK-based biotechnology company developing treatments to suppress unwanted innate immune responses, closed Series A financing of £5.3m. The round was led by existing investors Mercia ...
Article found on: www.finsmes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here